Technical Analysis for CPH - Cipher Pharmaceuticals Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | -2.99% | |
| Bollinger Band Squeeze | Range Contraction | -2.99% | |
| Outside Day | Range Expansion | -2.99% | |
| Oversold Stochastic | Weakness | -2.99% | |
| Crossed Above 20 DMA | Bullish | -1.46% | |
| Stochastic Buy Signal | Bullish | -1.46% | |
| Bollinger Band Squeeze | Range Contraction | -1.46% | |
| Narrow Range Bar | Range Contraction | -1.46% | |
| Gapped Up | Strength | -1.46% | |
| Oversold Stochastic | Weakness | -1.46% |
| Alert | Time |
|---|---|
| 20 DMA Support | about 1 hour ago |
| Gap Down Partially Closed | about 2 hours ago |
| Gapped Down (Partial) | about 2 hours ago |
| Down 3% | about 2 hours ago |
| Down 2% | about 2 hours ago |
Get a Trading Assistant
- Earnings date: 2024-05-09
Cipher Pharmaceuticals Inc. Description
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharma Pipe Pharmaceutical Pipeline RTT Skin Pharmaceuticals IPO Organ Systems Arthritis Ulcer Dermatology Nail Psoriasis Acne Actinic Keratosis Herpes Labialis Keratosis Onychomycosis Rheumatoid Arthritis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 10.33 |
| 52 Week Low | 3.3 |
| Average Volume | 47,170 |
| 200-Day Moving Average | 6.173 |
| 50-Day Moving Average | 8.672 |
| 20-Day Moving Average | 8.821 |
| 10-Day Moving Average | 8.904 |
| Average True Range | 0.354 |
| RSI (14) | 55.36 |
| ADX | 31.03 |
| +DI | 38.166 |
| -DI | 19.547 |
| Chandelier Exit (Long, 3 ATRs) | 9.268 |
| Chandelier Exit (Short, 3 ATRs) | 9.432 |
| Upper Bollinger Bands | 9.335 |
| Lower Bollinger Band | 8.307 |
| Percent B (%b) | 0.69 |
| BandWidth | 11.655 |
| MACD Line | 0.085 |
| MACD Signal Line | 0.110 |
| MACD Histogram | -0.0247 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.500 | ||||
| Resistance 3 (R3) | 9.450 | 9.240 | 9.420 | ||
| Resistance 2 (R2) | 9.240 | 9.118 | 9.265 | 9.393 | |
| Resistance 1 (R1) | 9.130 | 9.042 | 9.185 | 9.180 | 9.367 |
| Pivot Point | 8.920 | 8.920 | 8.948 | 8.945 | 8.920 |
| Support 1 (S1) | 8.810 | 8.798 | 8.865 | 8.860 | 8.673 |
| Support 2 (S2) | 8.600 | 8.722 | 8.625 | 8.647 | |
| Support 3 (S3) | 8.490 | 8.600 | 8.620 | ||
| Support 4 (S4) | 8.540 |
